Research News
OCRA-Funded Research Provides a New Understanding of Ovarian Cancer Biology
OCRA-funded researcher Anil K. Sood, M.D., lead and senior author, and Sanghoon Lee, Ph.D…
Oral Contraceptives Tied to Lower Long-Term Ovarian Cancer Risk
A recent study, published in Cancer Research and reported in The New York Times, suggests that risk-reduction associated with oral contraceptive use can last a lifetime…
OCRA-Funded Research Discoveries in 2020
It’s hard to believe 2020 is almost over, and what a year it’s been…
OCRA Research Investigates Role of Extracellular Vesicles in Cancer Research
OCRA-funded researchers Dr. Sunila Pradeep and Dr…
Applying Computational Biology to Ovarian Cancer | Meet a Scientist
Could the next ovarian cancer breakthrough be traced back to a Commodore 64 home computer? After all, in some small measure, OCRA grantee Dr. Sohrab Shah is where he is today thanks to that now-antiquated instrument…
OCRA-Funded Scientists Further Study Gene Mutation Connected to Ovarian Cancer
An international collaborative of scientists, including Dr. Ronald Chandler at Michigan State University, studied ARID1A mutations, which are specific gene mutations observed in deep ovarian and deep infiltrating endometriosis…
Focusing on the Next Line of Defense Against Ovarian Cancer | Meet a Scientist
There is an 80% recurrence rate when it comes to ovarian cancer, so the question of ‘what next?’ takes on a huge importance. This is the question that Sarah Gitto, PhD, and her team in the Daniel J…
OCRA-Funded Research Shines Light on Genetic Factors that Contribute to Diagnosis
In order to understand the complexities of how gene mutations affect an ovarian cancer diagnosis, OCRA-funded researcher Alexander Nikitin, MD, PhD and colleagues looked to see which ones drive, or possibly delay, the onset of the disease…
Heated Intraperitoneal Chemotherapy Found to Improve Outcomes in Patients with Stage III Epithelial Ovarian Cancer
A new study found that patients who received heated intraperitoneal chemotherapy (HIPEC) after surgery lived almost 16 months longer than patients who were treated by surgery alone…
OCRA Partners with Microsoft’s AI for Health Initiative
Ovarian Cancer Research Alliance (OCRA) is thrilled to announce a groundbreaking partnership with Microsoft’s AI for Health initiative…
New York City Researches Preliminary Outcomes of COVID-19 for Gynecologic Cancer Patients
(August 6, 2020) Using medical records for 121 patients with gynecologic cancer and COVID-19, researchers were able to conduct an early look at the implications of a COVID-19 diagnosis on a patient with a gynecological cancer diagnosis…
OCRA-Funded Study Finds Menopausal Hormone Therapy Associated with Improved Survival from Ovarian Cancer
(July 27, 2020) Research from the Ovarian Cancer Association Consortium (OCAC) found that “using menopausal hormone therapy prior to diagnosis extends ovarian cancer survival…